E-LIB Suche - Ergebnisse für: Delord, J.P.

1

Inequality factors in access to early-phase clinical trials..:

Charton, E. ; Baldini, C. ; Fayet, Y....
ESMO Open. 8 (2023) 4 - p. 101610 , 2023

Link: https://doi.org/10.1016/..

2

Access to early-phase clinical trials in older patients wit..:

Baldini, C. ; Charton, E. ; Schultz, E....
ESMO Open. 7 (2022) 3 - p. 100468 , 2022

Link: https://doi.org/10.1016/..

3

Delayed care for patients with newly diagnosed cancer due t..:

Blay, J.Y. ; Boucher, S. ; Le Vu, B....
ESMO Open. 6 (2021) 3 - p. 100134 , 2021

Link: https://doi.org/10.1016/..

4

Immunothérapie au plus proche du patient : l'expérience du ..:

Pages, C. ; Vildary, C. ; Boulanger, P....
Annales de Dermatologie et de Vénéréologie. 147 (2020) 12 - p. A314-A315 , 2020

Link: https://doi.org/10.1016/..

5

The prognostic impact of immune-related adverse events duri..:

Dupont, R. ; Bérard, E. ; Puisset, F....
OncoImmunology. 9 (2019) 1 - p. , 2019

Link: https://doi.org/10.1080/..

6

Activity of the FGFR1–3 inhibitor infigratinib in patients ..:

De Giorgi, U. ; Pal, S.K. ; Rosenberg, J.E....
European Urology Supplements. 18 (2019) 11 - p. e3405-e3406 , 2019

Link: https://doi.org/10.1016/..

7

Traitement médical ou chirurgical des cancers de l'orophary..:

Modesto, A. ; Galissier, T. ; Lusque, A....
Cancer/Radiothérapie. 21 (2017) 6-7 - p. 690 , 2017

Link: https://doi.org/10.1016/..

8

Radiothérapie et immunothérapie anti-PD-1 concomitante chez..:

Aboudaram, A. ; Meyer, N. ; Chaltiel, L....
Cancer/Radiothérapie. 21 (2017) 6-7 - p. 721-722 , 2017

Link: https://doi.org/10.1016/..

9

La photo-onycholyse, une nouvelle manifestation de phototox..:

Negulescu, M. ; Baran, R. ; Boulinguez, S....
Annales de Dermatologie et de Vénéréologie. 143 (2016) 12 - p. S412-S413 , 2016

Link: https://doi.org/10.1016/..

10

Place du curage ganglionnaire avant radiothérapie exclusive..:

Modesto, A. ; Sarini, J. ; Benlyazid, A....
Cancer/Radiothérapie. 20 (2016) 1 - p. 18-23 , 2016

Link: https://doi.org/10.1016/..

11

Prediction of long-term cumulative incidences based on shor..:

Cabarrou, B. ; Belin, L. ; Somda, S. M....
Breast Cancer Research and Treatment. 156 (2016) 3 - p. 577-585 , 2016

Link: https://doi.org/10.1007/..

12

Idelalisib improves CD37 antibody BI 836826 cytotoxicity ag..:

Betrian, S ; Ysebaert, L ; Heider, K H...
Blood Cancer Journal. 6 (2016) 11 - p. e496-e496 , 2016

Link: https://doi.org/10.1038/..

13

A phase Ib trial with MK-8628/OTX015, a small molecule inhi..:

Massard, C. ; Soria, J.C. ; Stathis, A....
European Journal of Cancer. 69 (2016) - p. S2-S3 , 2016

Link: https://doi.org/10.1016/..

14

Immunothérapie anti-PD-1 et radiothérapie concomitante dans..:

Modesto, A. ; Aboudaram, A. ; Chaltiel, L....
Annales de Dermatologie et de Vénéréologie. 143 (2016) 12 - p. S199 , 2016

Link: https://doi.org/10.1016/..

15

T‐DM1 extravasation: first description:

Sibaud, V. ; Nougarolis, S. ; Borjesson, C....
Journal of the European Academy of Dermatology and Venereology. 30 (2015) 7 - p. 1235-1236 , 2015

Link: https://doi.org/10.1111/..